Literature DB >> 24705944

Phenotypic variability in two families of Muenke syndrome with FGFR3 mutation.

Ankur Singh1, Manisha Goyal, Somesh Kumar, Wolfram Kress, Seema Kapoor.   

Abstract

Muenke syndrome is a nonsyndromic coronal craniosynostosis, characterised by clinical and radiological variability, with occurrence of both familial and sporadic cases. Pro250Arg (P250R) is a pathogenic mutation, causing this highly clinically heterogeneous syndrome reported worldwide irrespective of race and ethnicity. The authors describe three Indian cases in two different families showing phenotypic spectrum of the disease, which was later confirmed by genetic testing.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24705944     DOI: 10.1007/s12098-014-1424-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis.

Authors:  Andrew O M Wilkie; Jo C Byren; Jane A Hurst; Jayaratnam Jayamohan; David Johnson; Samantha J L Knight; Tracy Lester; Peter G Richards; Stephen R F Twigg; Steven A Wall
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

2.  A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.

Authors:  M Muenke; K W Gripp; D M McDonald-McGinn; K Gaudenz; L A Whitaker; S P Bartlett; R I Markowitz; N H Robin; N Nwokoro; J J Mulvihill; H W Losken; J B Mulliken; A E Guttmacher; R S Wilroy; L A Clarke; G Hollway; L C Adès; E A Haan; J C Mulley; M M Cohen; G A Bellus; C A Francomano; D M Moloney; S A Wall; A O Wilkie
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

3.  Identification of a genetic cause for isolated unilateral coronal synostosis: a unique mutation in the fibroblast growth factor receptor 3.

Authors:  K W Gripp; D M McDonald-McGinn; K Gaudenz; L A Whitaker; S P Bartlett; P M Glat; L B Cassileth; R Mayro; E H Zackai; M Muenke
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

4.  Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis.

Authors:  D M Moloney; S A Wall; G J Ashworth; M Oldridge; I A Glass; C A Francomano; M Muenke; A O Wilkie
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

5.  New Zealand Maori family with the pro250arg fibroblast growth factor receptor 3 mutation associated with craniosynostosis.

Authors:  S B Moko; T M Blandin de Chalain
Journal:  J Craniomaxillofac Surg       Date:  2001-02       Impact factor: 2.078

6.  Ocular phenotype correlations in patients with TWIST versus FGFR3 genetic mutations.

Authors:  Suzanne K Jadico; Alexandra Huebner; Donna M McDonald-McGinn; Elaine H Zackai; Terri L Young
Journal:  J AAPOS       Date:  2006-10       Impact factor: 1.220

7.  Significant phenotypic variability of Muenke syndrome in identical twins.

Authors:  Luis F Escobar; Adam K Hiett; Anne Marnocha
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

8.  A Korean family with the Muenke syndrome.

Authors:  Jae Eun Yu; Dong Ha Park; Soo Han Yoon
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

9.  Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature.

Authors:  Emily S Doherty; Felicitas Lacbawan; Donald W Hadley; Carmen Brewer; Christopher Zalewski; H Jeff Kim; Beth Solomon; Kenneth Rosenbaum; Demetrio L Domingo; Thomas C Hart; Brian P Brooks; Ladonna Immken; R Brian Lowry; Virginia Kimonis; Alan L Shanske; Fernanda Sarquis Jehee; Maria Rita Passos Bueno; Carol Knightly; Donna McDonald-McGinn; Elaine H Zackai; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2007-12-15       Impact factor: 2.802

  9 in total
  1 in total

1.  Muenke syndrome: Medical and surgical comorbidities and long-term management.

Authors:  Chaya N Murali; Donna M McDonald-McGinn; Tara Lynn Wenger; Carey McDougall; Bridget M Stroup; Sarah E Sheppard; Jesse Taylor; Scott P Bartlett; Elizabeth J Bhoj; Elaine H Zackai; Avni Santani
Journal:  Am J Med Genet A       Date:  2019-05-20       Impact factor: 2.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.